Business description
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. (Artivion) is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult clinical challenges in treating patients with aortic diseases. This multinational company's four major groups of products include: aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. Artivion markets and sells products in more than 100 countries worldwide.
Management board & Supervisory board
| CEO |
| J. Patrick Mackin |
| Management board |
| Amy D. Horton, Andrew Green, D. Ashley Lee, Dennis Maier, Jean F. Holloway, John Davis, Marshall Stanton, Matthew Getz, Peter Barthold, Rochelle L. Maney |
| Supervisory board |
| J. Patrick Mackin, Daniel J. Bevevino, Harvey Morgan, James W. Bullock, Jeffrey H. Burbank, Jon W. Salveson, Marna P. Borgstrom, Ronald D. McCall, Thomas F. Ackerman |
Company data
| Name: |
Artivion, Inc. |
| Address: |
1655 Roberts Boulevard, NW,Kennesaw, Georgia 30144, USA |
| Phone: |
+1-770-419-3355 |
| Fax: |
+1-770-426-0031 |
| E-mail: |
-
|
| Internet: |
www.cryolife.com/ |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
12-31 |
| Free Float: |
63.90% |
| IPO date: |
- |
Investor relations
| Name: |
D. Ashley Lee |
| IR phone: |
- |
| IR Fax: |
- |
| IR e-mail: |
-
|
